Exact Sciences to Participate in March Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston

    Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando

    Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.02
-6.18 (-2.47%)
AAPL  273.20
+3.06 (1.13%)
AMD  236.60
-19.73 (-7.70%)
BAC  53.09
+0.64 (1.22%)
GOOG  282.08
-2.67 (-0.94%)
META  621.13
-14.82 (-2.33%)
MSFT  496.67
-10.49 (-2.07%)
NVDA  190.50
-4.71 (-2.41%)
ORCL  240.31
-10.00 (-4.00%)
TSLA  445.47
-16.60 (-3.59%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.